Thoraflex Hybrid Post-Market Study

Active, not recruitingOBSERVATIONAL
Enrollment

182

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

April 25, 2025

Study Completion Date

July 31, 2026

Conditions
Acute Aortic DissectionAortic RupturePenetrating Aortic UlcerAortic DissectionAortic Aneurysm, Thoracic
Interventions
BEHAVIORAL

EQ-5D-5L QOL questionnaire

Written questionnaire

Trial Locations (7)

30625

Hannover Medical School, Hanover

N6A 5A5

London Health Sciences Centre, University Hospital, London

Unknown

University of Ottawa Heart Institute, Ottawa

Toronto General Hospital, Toronto

University of Freiburg, Freiburg im Breisgau

Policlinico S.Orsola-Malpighi, Bologna

St Antonious Hospital, Nieuwegein

All Listed Sponsors
lead

Vascutek Ltd.

INDUSTRY

NCT03414866 - Thoraflex Hybrid Post-Market Study | Biotech Hunter | Biotech Hunter